Stay Tuned!

Subscribe to our newsletter to get our newest articles instantly!

Cision Press Releases

Total Voting Rights – Fidelity Emerging Markets Ltd





01 October 2024

 

FIDELITY EMERGING MARKETS LIMITED (the ‘Company’)

 

Legal Entity Identifier (LEI): 213800HWWQPUJ4K1GS84

 

TOTAL NUMBER OF VOTING RIGHTS AND CAPITAL

 

In accordance with DTR 5.6.1 of the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules, the Company would like to notify the market of the following:

 

During the month of September 2024, Fidelity Emerging Markets Limited repurchased 929,932 Participating Preference shares into Treasury. No Participating Preference shares were repurchased for cancellation.

 

No Participating Preference shares were issued.

 

As at 30 September 2024, the Company’s issued share capital consisted of 77,568,185 Participating Preference shares of no-par value, carrying one vote each and 1,000 founder shares, carrying one vote each. This figure also includes 5,581,229 Participating Preference shares held in Treasury, which attract no voting rights; therefore, the total number of voting rights in the Company is 71,986,956.

 

The above figure (71,986,956) may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules.

 

For further information, please contact:

 

Nira Mistry

For and on behalf of FIL Investments International

Company Secretary

07778 354 517

 




Source link

creativebharatgroup@gmail.com

About Author

Leave a comment

Your email address will not be published. Required fields are marked *

You may also like

Cision Press Releases

The Impact of Technology on the Construction Industry

  The construction industry, traditionally a sector resistant to rapid change, is undergoing a profound transformation driven
Cision Press Releases

Spermosens AB (publ) INTERIM REPORT JANUARY – JUNE 2024

The revised strategy positions Spermosens optimally to unlock the full potential of its groundbreaking product. Spermosens